Valeo Pharma Inc. provided revenue guidance for the fourth quarter of 2022. The company expects revenues in the fourth quarter to exceed $11 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.11 CAD | +22.22% | +4.76% | -38.89% |
04-25 | Transcript : Valeo Pharma Inc. - Shareholder/Analyst Call | |
03-22 | Valeo Pharma Inc. Announces Appointment of Al Moghaddam to Board of Directors | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.89% | 6.45M | |
+48.79% | 780B | |
+41.76% | 627B | |
+19.43% | 334B | |
+7.18% | 296B | |
+17.60% | 244B | |
-0.41% | 217B | |
+11.54% | 214B | |
+4.53% | 161B | |
-3.92% | 159B |
- Stock Market
- Equities
- VPH Stock
- News Valeo Pharma Inc.
- Valeo Pharma Inc. Provides Revenue Guidance for the Fourth Quarter of 2022